NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
9.89 USD
-0.52 (-5%)
9.89 USD
0 (0%)
Overall NUS gets a fundamental rating of 5 out of 10. We evaluated NUS against 35 industry peers in the Personal Care Products industry. Both the profitability and the financial health of NUS get a neutral evaluation. Nothing too spectacular is happening here. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 7.69%, NUS is doing good in the industry, outperforming 77.14% of the companies in the same industry.
NUS's Return On Equity of 13.70% is amongst the best of the industry. NUS outperforms 82.86% of its industry peers.
NUS has a Return On Invested Capital (4.08%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 12.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
The Profit Margin of NUS (7.02%) is better than 77.14% of its industry peers.
NUS's Operating Margin of 3.87% is in line compared to the rest of the industry. NUS outperforms 48.57% of its industry peers.
In the last couple of years the Operating Margin of NUS has declined.
With a Gross Margin value of 67.20%, NUS perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NUS has been increased compared to 1 year ago.
NUS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
NUS has an Altman-Z score of 3.79. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
NUS has a Altman-Z score of 3.79. This is in the better half of the industry: NUS outperforms 74.29% of its industry peers.
The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NUS (4.29) is better than 82.86% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
NUS's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. NUS outperforms 51.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.79 |
ROIC/WACC0.55
WACC7.42%
2.3 Liquidity
NUS has a Current Ratio of 2.15. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
NUS has a Current ratio (2.15) which is in line with its industry peers.
A Quick Ratio of 1.45 indicates that NUS should not have too much problems paying its short term obligations.
NUS has a Quick ratio of 1.45. This is comparable to the rest of the industry: NUS outperforms 54.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.29%, which is quite impressive.
NUS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.85% yearly.
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -12.10% in the last year.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
The Earnings Per Share is expected to grow by 36.15% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -5.71% on average over the next years.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.17, the valuation of NUS can be described as very cheap.
Based on the Price/Earnings ratio, NUS is valued cheaper than 91.43% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, NUS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.28, the valuation of NUS can be described as very cheap.
Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 6.28 |
4.2 Price Multiples
91.43% of the companies in the same industry are more expensive than NUS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.43% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.18 | ||
| EV/EBITDA | 4.22 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 36.15% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 2.53%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.49, NUS pays a bit more dividend than its industry peers.
NUS's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2Y36.15%
EPS Next 3YN/A
9.89
-0.52 (-5%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.02%
Inst Owner Change1.34%
Ins Owners2.08%
Ins Owner Change3.44%
Market Cap489.56M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price Target7.65 (-22.65%)
Short Float %4.77%
Short Ratio4.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 6.28 | ||
| P/S | 0.31 | ||
| P/FCF | 9.18 | ||
| P/OCF | 5.47 | ||
| P/B | 0.61 | ||
| P/tB | 0.73 | ||
| EV/EBITDA | 4.22 |
EPS(TTM)1.38
EY13.95%
EPS(NY)1.58
Fwd EY15.93%
FCF(TTM)1.08
FCFY10.9%
OCF(TTM)1.81
OCFY18.27%
SpS31.52
BVpS16.16
TBVpS13.58
PEG (NY)0.14
PEG (5Y)N/A
Graham Number22.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.79 |
F-Score6
WACC7.42%
ROIC/WACC0.55
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
Can you provide the valuation status for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
Can you provide the profitability details for NU SKIN ENTERPRISES INC - A?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
What is the valuation of NU SKIN ENTERPRISES INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.17 and the Price/Book (PB) ratio is 0.61.
Is the dividend of NU SKIN ENTERPRISES INC - A sustainable?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 10.87%.